Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)Product type:GuidanceProgramme:Health technology evaluationPublished: 30 April 2024
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) (TA965)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2024
Digital supported self-management technologies for adults with chronic obstructive pulmonary disease: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 15 August 2024
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Virtual Wards for COPD exacerbationsStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC
MT633 FreeO2 Automatic Oxygen TitrationStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
RespiraSense (MT736)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC